T1 Protein 374 380 COMBAT
T2 Gene 1166 1174 toxicity
T3 Condition 1356 1365 relapsing
T4 Organism 27 35 children
T5 Organism 228 236 children
T6 Biomarker 407 425 Biodifferentiating
T7 Organism 906 914 patients
T8 Intervention 391 395 Oral
T9 Gene 1440 1448 toxicity
T10 Condition 1366 1376 refractory
T11 Organism 1265 1273 children
T12 Protein 1286 1292 COMBAT
T13 Organism 1228 1236 children
T14 Condition 1366 1389 refractory malignancies
T15 Organism 576 584 children
T16 Condition 251 263 solid tumors
T17 Organism 712 720 patients
T18 Organism 1342 1350 patients
T19 Condition 41 51 refractory
T20 Gene 1194 1202 toxicity
T21 Condition 52 73 relapsed malignancies
T22 Organism 699 707 patients
